Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors

202043 citationsJournal Articlehybrid Open Access

Authors

Hjalmar Wadström · Karolinska Institutet

Andreas Pettersson · Karolinska Institutet

Johan Askling · Karolinska University Hospital

Abstract

The decreased occurrence of breast cancer in patients with RA is present already before RA diagnosis; these reduced risks are not readily explained by hormonal risk factors. Adjuvant antihormonal therapy for breast cancer does not seem to increase RA risk.

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of the Rheumatic Diseases

Volume 79, Issue 5, pp. 581-586

DOI: 10.1136/annrheumdis-2019-216756

Field-Weighted Citation Impact: 4.20